Vimarsana
Biggest News Aggregation in the World

Page 6 - Chembio Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chembio Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chembio Diagnostics Today - Breaking & Trending Today

Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Acquires $63,060.30 in Stock - Vimarsana News

Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Acquires $63,060.30 in Stock

Chembio Diagnostics, Inc. (NASDAQ:CEMI – Get Rating) major shareholder Credit Advisors Ll Perceptive acquired 140,134 shares of the stock in a transaction on Thursday, April 13th. The shares were purchased at an average price of $0.45 per share, for a total transaction of $63,060.30. Following the completion of the transaction, the insider now owns 4,694,234 […]

Test maker tries again to win shareholder approval for a merger - Vimarsana News

Test maker tries again to win shareholder approval for a merger

The Medford-based manufacturer of rapid tests hasn't been able to muster the 50.1% of shares needed to complete its merger with a French firm.

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. - Vimarsana News

Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

13.04.2023 - STRASBOURG, France, April 13, 2023 (GLOBE NEWSWIRE) - Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a ... Seite 1

APAC HIV Rapid Test Kits Market - Focused Insights 2023-2028: Featuring Abbott, OraSure Technologies, Bio-Rad Laboratories, ChemBio Diagnostics and Biomerieux - Vimarsana News

APAC HIV Rapid Test Kits Market - Focused Insights 2023-2028: Featuring Abbott, OraSure Technologies, Bio-Rad Laboratories, ChemBio Diagnostics and Biomerieux

/PRNewswire/ -- The "APAC HIV Rapid Test Kits Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. REPORT OVERVIEW...

StockNews.com Begins Coverage on Chembio Diagnostics (NASDAQ:CEMI) - Vimarsana News

StockNews.com Begins Coverage on Chembio Diagnostics (NASDAQ:CEMI)

StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the stock. Chembio Diagnostics Stock Performance Shares of Chembio Diagnostics stock opened at $0.45 on Thursday. The stock has a market cap of $16.35 million, a P/E […]

Source: wkrb13.com